Jordan Guillot
Overview
Explore the profile of Jordan Guillot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
61
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guillot J, Justice A, Gordon K, Skanderson M, Pariente A, Bezin J, et al.
J Gen Intern Med
. 2024 Jun;
39(16):3261-3270.
PMID: 38831248
Background: The role of potentially inappropriate medications (PIMs) in mortality has been studied among those 65 years or older. While middle-aged individuals are believed to be less susceptible to the...
2.
Guillot J, Rentsch C, Gordon K, Justice A, Bezin J
Pharmacoepidemiol Drug Saf
. 2022 Jul;
31(10):1056-1074.
PMID: 35780391
Background: Potentially inappropriate medications (PIMs) are medications contra-indicated in particular circumstances. We sought to characterize PIMs by level of polypharmacy by age, sex, and race/ethnicity. Methods: We performed a cross-sectional...
3.
Guillot J, Maumus-Robert S, Pariente A, Bezin J
Fundam Clin Pharmacol
. 2021 Sep;
36(2):405-413.
PMID: 34506043
Polypharmacy is a growing concern often described only in older people by cumulating all drugs taken. We aimed to describe chronic polypharmacy in France, regardless of age. A cross-sectional descriptive...
4.
Guillot J, Maumus-Robert S, Marceron A, Noize P, Pariente A, Bezin J
J Clin Med
. 2020 Nov;
9(11).
PMID: 33233595
We aimed to describe the burden represented by potentially inappropriate medications (PIMs) in chronic polypharmacy in France. We conducted a nationwide cross-sectional study using data from the French National Insurance...
5.
Neal S, Wood A, Ablett A, Gregory J, Guillot J, Macdonald H, et al.
Ther Adv Drug Saf
. 2020 Jun;
11:2042098620929852.
PMID: 32547728
Background: Anticholinergic burden (ACB) is a recognised risk factor for falls in older people; however, whether ACB in middle age predicts falls in later life is unknown. Methods: We examined...
6.
Guillot J, Maumus-Robert S, Bezin J
Therapie
. 2019 Nov;
75(5):407-416.
PMID: 31732240
Polypharmacy is considered as the administration of many drugs. It is a major public health concern, which is growing worldwide. The identification of polypharmacy relies on drug count on a...
7.
Ablett A, Wood A, Barr R, Guillot J, Black A, Macdonald H, et al.
Ann Epidemiol
. 2018 Jun;
28(8):557-562.e2.
PMID: 29937404
Purpose: To examine the cross-sectional association between anticholinergic medication burden (ACB) and a history of falls, bone mineral density, and low trauma fractures in middle-aged women aged under 65 years...